Telomir Pharmaceuticals, Inc. financial data

Symbol
TELO on Nasdaq
Location
100 Se 2 Nd St, Suite 2000 #1009, Miami, FL
State of incorporation
FL
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Feb 4, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 346 %
Debt-to-equity 40.2 %
Return On Equity -1.15K % -98.6%
Return On Assets -830 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 29.8M shares
Common Stock, Shares, Outstanding 29.8M shares +4.03%
Entity Public Float 113M USD
Weighted Average Number of Shares Outstanding, Basic 29.5M shares +8.18%
Weighted Average Number of Shares Outstanding, Diluted 29.5M shares +8.18%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 2.24M USD +42%
General and Administrative Expense 9.64M USD +1506%
Nonoperating Income (Expense) 15.4K USD
Net Income (Loss) Attributable to Parent -16.5M USD -26.5%
Earnings Per Share, Basic 0.56 USD/shares +16.7%
Earnings Per Share, Diluted 0.56 USD/shares +16.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Assets, Current 1.32M USD +204%
Assets 1.32M USD -72.3%
Liabilities, Current 681K USD -49%
Liabilities 681K USD -49%
Retained Earnings (Accumulated Deficit) -30.6M USD -118%
Stockholders' Equity Attributable to Parent 643K USD -81.3%
Liabilities and Equity 1.32M USD -72.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.94M USD -164%
Net Cash Provided by (Used in) Financing Activities 5.21M USD +608%
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 29.8M shares +4.03%
Common Stock, Par or Stated Value Per Share 0 USD/shares
Deferred Tax Assets, Valuation Allowance 7.18M USD +749%
Deferred Tax Assets, Gross 7.18M USD +749%
Deferred Tax Assets, Operating Loss Carryforwards 4.43M USD +1435%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 100M shares 0%
Additional Paid in Capital 31.2M USD +78.5%
Preferred Stock, Shares Outstanding 0 shares
Interest Expense 4.34M USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares